Elekta Kaiku
A digital therapeutics platform built on patient-reported outcomes monitoring and intelligent symptom tracking.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
€4.4m | Series A | ||
| Total Funding | 000k | ||
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 19 % | 56 % | - | 61 % | (17 %) | 42 % | 72 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (187 %) | (142 %) | - | (227 %) | (224 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (189 %) | (143 %) | (143 %) | (229 %) | (238 %) | (99 %) | (49 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Kaiku Health is a pioneering digital health company focused on improving the quality of life for cancer patients. The company operates a platform that provides personalized digital health interventions, specifically designed for individuals undergoing cancer treatment. By leveraging patient-reported outcome monitoring and intelligent symptom tracking, Kaiku Health aids cancer clinics in delivering optimized care through timely symptom management and streamlined workflows.
Kaiku Health primarily serves cancer patients and healthcare providers, including cancer clinics and life sciences organizations. The platform is currently utilized by thousands of cancer patients across more than 25 different cancer types, making it a significant player in the oncology sector. The company’s market spans multiple countries, including Finland, Sweden, Norway, Denmark, Germany, Austria, Switzerland, the United Kingdom, Ireland, Spain, Italy, France, Belgium, the Netherlands, Australia, New Zealand, the United States, Singapore, and Japan.
The business model of Kaiku Health revolves around providing a subscription-based service to cancer clinics and healthcare providers. These institutions pay for access to the platform, which helps them manage patient symptoms more effectively and improve overall care quality. Additionally, Kaiku Health collaborates with life sciences companies for research and development purposes, creating further revenue streams.
Kaiku Health makes money through these subscription fees and partnerships with life sciences companies. By offering a CE-marked MDD class I medical device, the platform ensures compliance with European health standards, adding a layer of credibility and trust for its users.
In summary, Kaiku Health is revolutionizing cancer care by offering a digital platform that enhances patient outcomes and supports healthcare providers in delivering timely and effective treatment.
Keywords: digital health, cancer care, patient monitoring, symptom tracking, oncology, personalized interventions, healthcare platform, cancer clinics, life sciences, patient outcomes.